X0206 3 2023-11-27 0 0001811063 Nuvation Bio Inc. NUVB 0002001938 Makunje Moses C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401 NEW YORK NY 10036 0 1 0 0 See Remarks Class A Common Stock 10612 D Stock Option (Right to Buy) 1.74 2030-07-21 Class A Common Stock 112704 D Stock Option (Right to Buy) 4.60 2030-10-04 Class A Common Stock 112704 D Stock Option (Right to Buy) 5.06 2032-02-27 Class A Common Stock 291000 D Stock Option (Right to Buy) 2.93 2032-08-28 Class A Common Stock 233000 D Stock Option (Right to Buy) 1.94 2033-02-27 Class A Common Stock 194000 D Option vests as to 25% on the one year anniversary of 7/21/2020, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. The shares subject to the Option will vest based on the satisfaction of both time-based and performance-based vesting criteria. As of November 27, 2023, 22,540 of the shares subject to the Option have vested. Option vests as to 25% on the one year anniversary of 2/28/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Option vests as to 25% on the one year anniversary of 8/29/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date. Title: VP, Finance and principal financial and accounting officer. Moses Makunje, by /s/ Ron A. Metzger, Attorney-in-Fact. 2023-11-27